All Press Releases

LabCentral Releases 2020 Impact Report: Companies Raised $3.7 Billion in Funding and 33% of 2020 Massachusetts Bio-Pharma IPOs Started in the LabCentral Network April 9, 2021

Resident and alumni companies also added 737 new jobs in 2020 – an increase of 56% over the previous year – and bringing the total added through LabCentral companies since 2013 to 3,132CAMBRIDGE,…Read full post

ONO Entered Sponsorship Agreements with LabCentral and MBC BioLabs February 25, 2021

Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Representative Director, Gyo Sagara; “ONO”) announced that it has entered sponsorship agreements with LabCentral (Cambridge, MA, U.S.) and MBC…Read full post

LabCentral Announces $22.4 Million in Committed Funding for LabCentral 238 including New Sponsors Thermo Fisher Scientific and Waters Corporation February 18, 2021

LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced a total of $22.4 million in sponsorship commitments for…Read full post

LabCentral Launches “LabCentral Ignite” – New Initiative to Advance Life Sciences Innovation by Expanding and Diversifying the Talent Base for the Biotech Industry January 13, 2021

Read full post

December 16, 2020

Read full post

US DOD Awards $10.5M Contract to Sunflower Therapeutics November 10, 2020

Read full post

LG Chem Life Sciences Innovation Center and LabCentral Announce the 2020 Golden Ticket Winner – Mediar Therapeutics - Accelerating Innovative Fibrosis Therapeutics October 30, 2020

Read full post

LabCentral Launches COVID-19 Rapid Testing Consortium in Partnership with BioLabs and E25Bio October 29, 2020

CAMBRIDGE, Mass., Oct. 29, 2020 --- LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced it has partnered…Read full post

LabCentral to Host Special Virtual Panel on Biotech Innovation in Space September 14, 2020

Read full post

LabCentral Alumni Sentien Biotechnologies Announces Open IND in Phase 1/2 Trial of SBI-101 for Patients with COVID-19 August 18, 2020

Read full post

2 3 4 ... 21